Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

NeuroPace (NPCE) Return on Equity (2020 - 2026)

NeuroPace has reported Return on Equity over the past 7 years, most recently at 0.01% for Q1 2026.

  • For Q1 2026, Return on Equity changed 0.0% year-over-year to 0.01%; the TTM value through Mar 2026 reached 0.01%, changed 0.0%, while the annual FY2025 figure was 0.02%, 0.0% changed from the prior year.
  • Return on Equity for Q1 2026 was 0.01% at NeuroPace, down from 0.01% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.01% in Q1 2022 and troughed at 0.03% in Q4 2024.
  • A 5-year average of 0.02% and a median of 0.01% in 2023 define the central range for Return on Equity.
  • Biggest five-year swings in Return on Equity: fell -1bps in 2022 and later grew 2bps in 2025.
  • Year by year, Return on Equity stood at 0.01% in 2022, then plummeted by -47bps to 0.02% in 2023, then tumbled by -75bps to 0.03% in 2024, then skyrocketed by 64bps to 0.01% in 2025, then decreased by -12bps to 0.01% in 2026.
  • Business Quant data shows Return on Equity for NPCE at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.